Effect of nucleos(t)ide analogue therapy on hepatocarcinogenesis in chronic hepatitis B patients: A propensity score analysis-Reference-Cited by-同舟云学术

Effect of nucleos(t)ide analogue therapy on hepatocarcinogenesis in chronic hepatitis B patients: A propensity score analysis

Published:2013-03 Issue:3 Volume:58 Page:427-433
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Kumada Takashi,Toyoda Hidenori,Tada Toshifumi,Kiriyama Seiki,Tanikawa Makoto,Hisanaga Yasuhiro,Kanamori Akira,Niinomi Takurou,Yasuda Satoshi,Andou Yusuke,Yamamoto Kenta,Tanaka Junko

Publisher

Elsevier BV

Subject

Hepatology

Reference50 articles.

1. EASL international consensus conference on hepatitis B, 13–14 September, 2002, Geneva, Switzerland, Consensus statement (short version);EASL Jury;J Hepatol,2003

2. Hepatitis B virus. The major etiology of hepatocellular carcinoma;Beasley;Cancer,1988

3. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan;Beasley;Lancet,1981

4. Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association;Szmuness;Prog Med Virol,1978

5. Epidemiology of hepatocellular carcinoma;Rustgi;Gastroenterol Clin North Am,1987

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current tests for diagnosis of hepatitis B virus infection and immune responses of HBV-related HCC;Frontiers in Oncology;2023-11-28

2. Hepatitis B core-related antigen: A novel and promising surrogate biomarker to guide anti-hepatitis B virus therapy;Clinical and Molecular Hepatology;2023-10-01

3. FIB‑4 index and serum α‑fetoprotein are useful predictors of hepatocellular carcinoma occurrence in hepatitis B patients with nucleos(t)ide analogs therapy;Experimental and Therapeutic Medicine;2023-08-01

4. The role of hepatitis B core-related antigen in predicting the occurrence and recurrence of hepatocellular carcinoma in patients with chronic hepatitis B: a systemic review and meta-analysis;2023-06-13

5. Serum HBcrAg and Hepatocellular Carcinoma in a Taiwanese Population Seronegative for HBsAg and Anti-HCV;Clinical Gastroenterology and Hepatology;2023-05